AMRX

Amneal Pharmaceuticals, Inc.

AMRX · CIK 1723128 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$3.0B
20182025
Net Income$0.1B
20182025
Operating CF$0.3B
20182025
Free Cash Flow$0.3B
20182025

Income Statement

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Revenue$3.0B$2.8B$2.4B$2.2B$2.1B$2.0B$0.4B$0.5B
Cost of Revenue$1.9B$1.8B$1.6B$1.4B$1.3B$1.3B$1.1B$0.9B
Gross Profit$1.1B$1.0B$0.8B$0.8B$0.8B$0.6B$0.1B$0.2B
R&D Expense$0.2B$0.2B$0.2B$0.2B$0.2B$0.2B$0.2B$0.2B
SG&A Expense$0.5B$0.5B$0.4B$0.4B$0.4B$0.3B$0.3B$0.2B
Operating Income$0.4B$0.2B$0.2B$-0.1B$0.2B$0.1B$-0.2B$-0.0B
Net Income$0.1B$-0.1B$-0.1B$-0.3B$0.0B$0.1B$-0.4B$-0.0B
EPS (Basic)$0.23$-0.38$-0.48$-0.86$0.07$0.62$-0.23$-0.07
EPS (Diluted)$0.22$-0.38$-0.48$-0.86$0.07$0.61$-0.23$-0.07

Balance Sheet

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Total Assets$3.7B$3.5B$3.5B$3.8B$3.9B$4.0B$3.7B$4.4B
Current Assets$1.9B$1.6B$1.4B$1.4B$1.5B$1.6B$1.2B$1.3B
Cash & Equivalents$0.3B$0.1B$0.1B$0.0B$0.2B$0.3B$0.2B$0.2B
Total Liabilities
Current Liabilities$0.9B$1.1B$0.8B$0.8B$0.7B$0.7B$0.6B$0.6B
Stockholders' Equity$-0.1B$-0.1B$0.0B$0.3B$0.4B$0.3B$0.2B$0.5B

Cash Flow Statement

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Operating Cash Flow$0.3B$0.3B$0.3B$0.1B$0.2B$0.4B$0.0B$0.3B
Investing Cash Flow$-0.1B$-0.1B$-0.1B$-0.2B$-0.2B$-0.3B$-0.0B$-0.4B
Capital Expenditures$0.1B$0.1B$0.0B$0.0B$0.0B$0.1B$0.0B$0.1B
Financing Cash Flow$-0.0B$-0.2B$-0.2B$-0.1B$-0.1B$0.1B$-0.0B$0.3B